SCHEMBL21361160

SCHEMBL21361160

COC(=O)C(NC(=O)CCCCCN(C)C(=O)CCCCC1SCC2NC(=O)NC21)OC(C)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 5/20 0.53
▸ MEN1 O00255 1/20 0.47
▸ ABL1 P00519 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ IDE P14735 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ RIN1 Q13671 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ FOLH1 Q04609 1/20 0.46
▸ F2 P00734 1/20 0.45
▸ PRSS1 P07477 1/20 0.45
▸ PRSS2 P07478 1/20 0.45
▸ PRSS3 P35030 1/20 0.45
▸ TPSAB1 Q15661 1/20 0.45
▸ CNR1 P21554 2/20 0.44
▸ HLCS P50747 3/20 0.44
▸ CA12 O43570 3/20 0.43
▸ CA1 P00915 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21361151 0.91 TDP1 (0.63) TDP1MEN1ABL1LMNAPKM
SCHEMBL21361155 0.89 TDP1 (0.49) TDP1MEN1ABL1LMNAPKM
SCHEMBL21361157 0.87 TDP1 (0.61) TDP1MEN1ABL1LMNAPKM
SCHEMBL21361159 0.86 TDP1 (0.55) TDP1MEN1ABL1LMNAPKM
SCHEMBL11974137 0.86 TDP1 (0.35) TDP1FOLH1F2PRSS1PRSS2
SCHEMBL903561 0.82 TDP1 (0.79) TDP1MEN1ABL1LMNAPKM
SCHEMBL15130513 0.81 TDP1 (0.61) TDP1MEN1ABL1LMNAPKM
SCHEMBL6036972 0.79 TDP1 (0.76) TDP1MEN1ABL1LMNAPKM
SCHEMBL15123570 0.79 TDP1 (0.76) TDP1MEN1ABL1LMNAPKM
SCHEMBL14159597 0.76 TDP1 (0.71) TDP1MEN1ABL1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10413621-B2 Composition and methods for imaging cells CASE WESTERN RESERVE UNIVERSITY (US) 2019-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10413621-B2 Composition and methods for imaging cells MCL1, TP53, HNRNPAB TDP1 3017/4885MEN1 413/4885ABL1 2926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback